https://www.linkedin.com/posts/rentschler-biopharma_scaling-up-biologics-manufacturing-solutions-activity-7371171161180782592-HlGA?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAGBIr0BAP_3y98KQZnfRhIRQ-kqOWXe0fc

Scaling up biologics manufacturing remains a topic in our industry.  At DCAT Week, experts across the sector joined our colleagues Jessica Feldman, PhD and Henning Gerschewski to discuss how collaboration, innovation, and cutting-edge technology are reshaping the journey from clinical to commercial readiness. 
 
From overcoming capacity constraints to ensuring product quality at scale, the discussion made it clear: scaling up isn’t just about equipment or space, it’s about strategy, partnerships, and the right expertise. 
 
Want to learn more? Then download the full discussion recap “How collaboration and technology are transforming integrated biologics manufacturing workflows”: https://lnkd.in/eWHG344T 
 
Interested in discovering how we help clients scale up reliably with confidence? Let’s connect! 

See all Member News